| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2005 | WO2004073636A3 Compositions comprising a polysaccharide component and one or more coating layers |
| 04/14/2005 | WO2004071427A3 Screening and treatment methods for prevention of preterm delivery |
| 04/14/2005 | WO2004069796A8 Process for producing levetiracetam |
| 04/14/2005 | WO2004066967B1 Method and kit for reducing the symptoms of peripheral vascular disease |
| 04/14/2005 | WO2004060341B1 Increasing skin cell renewal with water-soluble vitamin e |
| 04/14/2005 | WO2004036182A3 Methods for monitoring treatment of disease |
| 04/14/2005 | WO2004029208A3 Cell separation compositions and methods |
| 04/14/2005 | WO2004024069A3 Novel compositions and methods for the treatment of immune-related diseases |
| 04/14/2005 | WO2004014295A3 Tiacumicin production |
| 04/14/2005 | WO2004013120A8 Novel benzodioxoles |
| 04/14/2005 | WO2003090678A3 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 04/14/2005 | WO2003084529A8 Low-pressure mercury vapor discharge lamp |
| 04/14/2005 | WO2003084475A3 INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | WO2003070971A3 Modulators of paraptosis and related methods |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | US20050080468 Methods and apparatus for treating diseased tissue |
| 04/14/2005 | US20050080299 Method for the preparation of matairesinol |
| 04/14/2005 | US20050080283 Pharmaceutical-grade ferric citrate |
| 04/14/2005 | US20050080275 Process for the preparation of simvastatin |
| 04/14/2005 | US20050080266 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 04/14/2005 | US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor |
| 04/14/2005 | US20050080255 Reacting cefdinir with potassium compound; salt formation; crystallization from solvent |
| 04/14/2005 | US20050080144 Oligoamine compounds and derivatives thereof for cancer therapy |
| 04/14/2005 | US20050080143 administering toremifene, and its pharmaceutically acceptable salt, hydrate, N-oxide or mixtures for prophylaxis of bone disorders; antiestrogens |
| 04/14/2005 | US20050080142 Using (bi)guanidine compound in aqueous solution; preventing Legionnaire's Disease |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080140 Administering peroxisome proliferator-activated receptor (PPAR) delta agonist; a prostacyclin synthase gene or a protein encoded by the gene; rheumatoid arthritis, osteoarthritis, Crohn's disease, Guillain-Barre syndrome, skin disorders, post by-pass surgery restenosis, transplantation rejection |
| 04/14/2005 | US20050080139 Reducing or preventing glutamate-induced excitotoxicity, which will cause neuronal damage or death; administering an enzyme inhibitor 2-[(4-carboxyphenyl)sulfonyl]-1,4-benzene-dicarboxylic acid |
| 04/14/2005 | US20050080137 Laxative preparation |
| 04/14/2005 | US20050080136 Spray drying in the presence of trehalose, then granulating and drying; leucine, isoleucine, valine powders; oral meltability and solubility and a high masking effect of the taste |
| 04/14/2005 | US20050080135 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines |
| 04/14/2005 | US20050080134 Preparing anticholesterol agent by salt formation, purification; free of impurities on an industrial scale; lower LDL-cholesterol and triglycerides |
| 04/14/2005 | US20050080133 Methods of inhibiting osteoclast activity |
| 04/14/2005 | US20050080132 Composition and method to treat solid tumors |
| 04/14/2005 | US20050080130 Compounds foriImaging alzheimer's disease |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080128 Indoles as naaladase inhibitors |
| 04/14/2005 | US20050080125 Treatment is directed to drug induced obesity in juvenile or adolescent patients; psychiatric disorders; cannabinoid receptors; cannabis-1 (CB1) receptor antagonists |
| 04/14/2005 | US20050080122 Anti-viral compounds |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080120 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080118 Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080116 Compounds useful as motilin agonists and method |
| 04/14/2005 | US20050080114 Crystallization of rosiglitazone maleate; SUITABLE FOR BULK PREPARATION AND HANDLING; industrial scale production; hypoglycemic agents; treating diabetes |
| 04/14/2005 | US20050080113 Medicinal compositions |
| 04/14/2005 | US20050080112 Compounds for use in disorders associated with mast cell or basophil acitvity |
| 04/14/2005 | US20050080110 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/14/2005 | US20050080109 Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis |
| 04/14/2005 | US20050080108 such as (S)-1-ethyl-5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid-[2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]amide; for treatment of obesity and lipid disorders; diabetes |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050080105 3-thia-4-arylquinolin-2-one derivatives |
| 04/14/2005 | US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate |
| 04/14/2005 | US20050080103 Radioactivity free; free basing cocaine with baking soda |
| 04/14/2005 | US20050080102 Compound and uses thereof |
| 04/14/2005 | US20050080099 Methods and kits for treating depression or preventing deterioration of cognitive function |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080093 Administering sodium channel modulators such as N-[4-(4-{2-[bis-((2S,3R)-2,3,4-trihydroxybutyl)amino]ethoxy}phenyl)butyl]-N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidine dihydrochloride |
| 04/14/2005 | US20050080092 Such as N-(6-aminohexyl)-N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidine Dihydrochloride; for hydration of mucosal surfaces, treating chronic bronchitis, cystic fibrosis, sinusitis, vaginal dryness, dry eye, esophogitis, emphysema, and pneumonia |
| 04/14/2005 | US20050080091 Capped pyrazinoylguanidine sodium channel blockers |
| 04/14/2005 | US20050080089 Formulations comprising triazoles and alkoxylated amines |
| 04/14/2005 | US20050080088 Novel compounds |
| 04/14/2005 | US20050080085 Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof |
| 04/14/2005 | US20050080084 Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of central nervous system damage |
| 04/14/2005 | US20050080083 Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin II receptor antagonist for the treatment of central nervous system damage |
| 04/14/2005 | US20050080081 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/14/2005 | US20050080080 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2005 | US20050080078 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction |
| 04/14/2005 | US20050080076 N-desmethyl levomepromazine |
| 04/14/2005 | US20050080075 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080072 Such as 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-pinerazinyl]dibenzo[b,f][1,4]thiazepine (quetiapine) via reduction, cyclization, and deprotection |
| 04/14/2005 | US20050080071 Treatment methods |
| 04/14/2005 | US20050080069 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080066 Antiglucocorticoids for the treatment of catatonia |
| 04/14/2005 | US20050080064 Steroids as agonists for fxr |
| 04/14/2005 | US20050080062 preventing or delaying the progression of hormone receptor breast cancer following estrogen antagonist therapy by subsequent therapy with an estrogen depleting agent prior to disease progression |
| 04/14/2005 | US20050080061 inhibit the binding of cortisol to its receptors; Mifepristone; dexamethasone and betamethasone |
| 04/14/2005 | US20050080060 Antigestagenically active steroids with a fluorinated 17alpha-alkyl chain |
| 04/14/2005 | US20050080059 ulcerative colitis and Crohn's disease; 1 alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol or 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 |
| 04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/14/2005 | US20050080057 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
| 04/14/2005 | US20050080056 Alpha 1 antagonist; reduces pupil size in dim light, but less reduction in pupil size in bright light; artificial tear; tamsulosin, urapidil |
| 04/14/2005 | US20050080055 Method of treating breast cancer with androgen receptor antagonists |
| 04/14/2005 | US20050080053 treatment of RNA viral infections such as HCV, HBV, small pox, Ebola, polio, West Nile, Coxsackie A and B, Rhino, and Echo viral infection; viricides |
| 04/14/2005 | US20050080052 Fine dry powder; rapidly spreads and melts over lung and air passageway surfaces |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080050 Lipid analogs for treating viral infections |
| 04/14/2005 | US20050080049 Applying a composition of phospholipid complexes of standardized extract of Vitis vinifera, phospholipid complexes of standardized extract of Centella asiatica, excipients, and carriers; antiwrinkling agent |
| 04/14/2005 | US20050080046 In liquid solvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/14/2005 | US20050080045 topical administration; prevention of STDs preferably a viral disease other than HIV, e.g. HPV or genital herpes and especially acyclovir resistant genital herpes |
| 04/14/2005 | US20050080042 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 04/14/2005 | US20050080041 Method and composition for the treatment of adenoviral ocular infections |
| 04/14/2005 | US20050080039 Pectin films prepared from gamma irradiated pectin |